Skip to main content

Labcorp Holdings (LH) Receives a Hold from Piper Sandler

Tipranks - Tipranks - Wed Feb 25, 5:40AM CST

In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Labcorp Holdings, with a price target of $300.00.

Claim 50% Off TipRanks Premium

Westenberg covers the Healthcare sector, focusing on stocks such as Natera, Adaptive Biotechnologies, and GeneDx Holdings. According to TipRanks, Westenberg has an average return of 9.9% and a 48.71% success rate on recommended stocks.

In addition to Piper Sandler, Labcorp Holdings also received a Hold from TipRanks – xAI’s xAi Medical – Equipment and Services in a report issued on February 18. However, on the same day, Morgan Stanley maintained a Buy rating on Labcorp Holdings (NYSE: LH).

See the top stocks recommended by analysts >>

Based on Labcorp Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.52 billion and a net profit of $164.7 million. In comparison, last year the company earned a revenue of $3.33 billion and had a net profit of $143.4 million

Read More on LH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).